Pharmaceuticals (45) | Change of Control Agreements (45)
Browse by Company
-
Aclaris Therapeutics, Inc. (1)
-
ALIMERA SCIENCES INC (1)
-
Athira Pharma, Inc. (8)
-
Corcept Therapeutics Incorporated (7)
-
DiCE MOLECULES HOLDINGS, LLC (1)
-
DURECT CORP (1)
-
Edgewise Therapeutics, Inc. (1)
-
Eloxx Pharmaceuticals, Inc. (1)
-
EYEGATE PHARMACEUTICALS INC (1)
-
GRAYBUG VISION, INC. (1)
-
GW PHARMACEUTICALS PLC (7)
-
Jaguar Health, Inc. (1)
-
Jazz Pharmaceuticals plc (2)
-
Lilly (Eli) & Co. (1)
-
Liquidia Corp (2)
-
MyoKardia Inc (2)
-
Perrigo (1)
-
Rani Therapeutics Holdings, Inc. (2)
-
Satsuma Pharmaceuticals, Inc. (1)
-
Theravance Biopharma, Inc. (1)
-
Ventyx Biosciences, Inc. (1)
-
Verona Pharma plc (1)
Recent Contracts
-
First Amendment to the Theravance Biopharma, Inc. Change in Control Severance Plan
(Theravance Biopharma, Inc., Filed With SEC on November 9, 2022)
-
Executive Change in Control and Severance Plan
(Ventyx Biosciences, Inc., Filed With SEC on May 9, 2022)
-
Change in Control and Severance Agreement between the Registrant and Kevin Church
(Athira Pharma, Inc., Filed With SEC on March 28, 2022)
-
Severance and Change in Control Agreement by and between Corcept Therapeutics Incorporated and William Guyer, dated February 9, 2022
(Corcept Therapeutics Incorporated, Filed With SEC on February 15, 2022)
-
Amended and Restated Change in Control and Severance Agreement between the Company and Mark Litton, Ph.D
(Athira Pharma, Inc., Filed With SEC on January 31, 2022)
-
Change in Control Severance Agreement between Alimera Sciences, Inc., and Philip J. Ashman, Ph.D. as of July 16, 2021
(ALIMERA SCIENCES INC, Filed With SEC on November 5, 2021)
-
Form of Change in Control and Severance Agreement
(DiCE MOLECULES HOLDINGS, LLC, Filed With SEC on September 9, 2021)
-
Change in Control and Severance Agreement between the Registrant and Rachel Lenington
(Athira Pharma, Inc., Filed With SEC on August 16, 2021)
-
Change in Control and Severance Agreement between the Registrant and Mark Worthington
(Athira Pharma, Inc., Filed With SEC on August 16, 2021)
-
Verona Pharma plc Employee Change in Control Severance Benefit Plan
(Verona Pharma plc, Filed With SEC on August 11, 2021)